Results 111 to 120 of about 10,054 (222)

Evaluating Basophil Histamine Content as a Biomarker for Omalizumab Responsiveness in Chronic Spontaneous Urticaria

open access: yes
Clinical &Experimental Allergy, EarlyView.
Ditte Georgina Zhang   +4 more
wiley   +1 more source

OX40/OX40L modulation: A target for regulating T cells in cutaneous inflammatory disorders

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
OX40 and OX40L are a co‐stimulatory immune checkpoint pair. Modulation of this pair impacts multiple immune phenotypes and is an attractive target for immunotherapy in dermatological disorders. Trials are underway with the majority in atopic dermatitis and currently in phase 3 trials.
Aditya K. Gupta   +4 more
wiley   +1 more source

Omalizumab in the Treatment of Urticaria

open access: yes
167176Omalizumab is a humanized mouse monoclonal IgG1 antibody directed against the third heavy chain domain of IgE. It has been approved for moderate to severe asthma since 2003, for adults and adolescents with chronic spontaneous urticaria unresponsive
Zuberbier, Torsten   +3 more
core   +1 more source

Autologous Serum Therapy in Recalcitrant Chronic Spontaneous Urticaria: Experience from Three Dermatology Clinics in Malaysia

open access: yesIndian Journal of Dermatology
Autohemotherapy is a commonly used treatment for recalcitrant chronic urticaria in some countries. Herein we report our experience using autologous serum therapy in eight patients with recalcitrant chronic spontaneous urticaria.
Ingrid Ting Pao Lin   +5 more
doaj   +1 more source

Disease modification in chronic spontaneous urticaria

open access: yesAllergy
AbstractChronic spontaneous urticaria (CSU) is a debilitating, inflammatory skin condition characterized by infiltrating immune cells. Available treatments are limited to improving the signs and symptoms. There is an unmet need to develop therapies that target disease‐driving pathways upstream of mast cell activation to inhibit or delay the progression
Marcus, Maurer   +26 more
openaire   +2 more sources

A Meta‐Analysis of Anti‐Thyroid Peroxidase Antibody and Omalizumab Response in Chronic Spontaneous Urticaria

open access: yes
Clinical &Experimental Allergy, EarlyView.
Ju Hyun Lee   +4 more
wiley   +1 more source

Pathophysiology and emerging treatments for dermographic, cholinergic and cold urticaria

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
This review illustrates key proposed mast cell‐mediated activation pathways in dermographic, cholinergic and cold urticaria, highlighting IgE‐dependent and ‐independent mechanisms. These pathways are increasingly targeted by emerging drugs, aiming to interrupt mast cell activation and mediator release, offering more precise, mechanism‐based treatment ...
Mojca Bizjak‐Suran   +2 more
wiley   +1 more source

Neurotrophins: Are They Meaningful in Chronic Spontaneous Urticaria?

open access: yes, 2021
Plasma neurotrophin levels are elevated in patients with allergic and autoimmune diseases. The present study was designed to investigate the serum neurotrophin levels in 42 patients displaying chronic spontaneous urticaria, as well as 22 healthy control ...
Buyukozturk, Suna   +10 more
core  

The role of antibiotics in preventing surgical complications in periodontology and implant dentistry

open access: yesPeriodontology 2000, EarlyView.
Abstract Antibiotics are commonly prescribed in periodontal and implant surgeries, either before, during or after surgery, to prevent postoperative infection and reduce early implant failure. However, the potential benefits may be undermined by the risks of resistance and sensitization, thus requiring a strict indication for prescription.
Zhaozhao Chen   +3 more
wiley   +1 more source

Clinical Findings, Treatment Recommendations, and Outcome in Dogs Following Ingestion of a Single Unintended Dose of Trilostane: 403 Cases (2008–2023)

open access: yesJournal of Veterinary Emergency and Critical Care, EarlyView.
ABSTRACT Objective To characterize the clinical signs and outcomes in dogs following ingestion of a single, unintended dose of trilostane. The secondary objective was to describe treatment recommendations given for this population. Design Retrospective evaluation of cases of canine trilostane exposure from February 2008 to August 2023. Setting Private,
Lindsey Summers   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy